IMPACT OF OPIOID DEPRESCRIBING AND TAPERING ON MENTAL HEALTH AND SOCIAL FUNCTIONING IN PATIENTS WITH CHRONIC NON – CANCER PAIN: AN OVERVIEW OF CURRENT EVIDENCE
DOI:
https://doi.org/10.31435/ijitss.3(51).2026.5934Keywords:
Mental Health; Depression; Chronic Pain; Pain Management; Opioid CrisisAbstract
Background. Long-term opioid therapy for chronic non-cancer pain is associated with numerous adverse effects, including psychological distress, dependence, and impaired functioning. In response to growing concerns about opioid-related harms, opioid deprescribing and tapering strategies have gained increasing attention in clinical practice. However, their impact on patients’ mental health and social functioning remains incompletely understood.
Aim. This review aimed to evaluate the available evidence on the effects of opioid deprescribing and tapering on mental health and social functioning in patients with chronic non-cancer pain.
Material and methods. A literature review was conducted using major biomedical databases, including PubMed, MEDLINE, Scopus, Web of Science, and the Cochrane Library. Eligible studies included peer-reviewed articles examining opioid deprescribing or tapering in adults with chronic non-cancer pain and reporting outcomes related to mental health, social functioning, or patient-reported functioning
Results. The available evidence suggests that patients undergoing opioid deprescribing frequently present with substantial psychological distress, including depression, anxiety, and pain catastrophizing. Mental health outcomes during tapering are heterogeneous and influenced by the pace of dose reduction, patient involvement in decision making, and access to psychological support. Qualitative studies commonly highlight social factors: stigma, communication with healthcare providers, and availability of alternative pain management strategies.
Conclusions. Opioid deprescribing in patients with chronic non-cancer pain represents a complex clinical process with potential implications for both mental health and social functioning. Individualized tapering strategies, patient involvement in treatment decisions, and adequate psychological and multidisciplinary support appear essential for minimizing adverse outcomes and improving patient experiences during opioid dose reduction.
References
Benintendi, A., Kosakowski, S., Lagisetty, P., Larochelle, M., Bohnert, A. S. B., & Bazzi, A. R. (2021). “I felt like I had a scarlet letter”: Recurring experiences of structural stigma surrounding opioid tapers among patients with chronic, non-cancer pain. Drug and Alcohol Dependence, 222, 108664. https://doi.org/10.1016/j.drugalcdep.2021.108664
Dowell, D., Ragan, K. R., Jones, C. M., Baldwin, G. T., & Chou, R. (2022). CDC clinical practice guideline for prescribing opioids for pain—United States, 2022. MMWR Recommendations and Reports, 71(3), 1–95. https://doi.org/10.15585/mmwr.rr7103a1
Eccleston, C., Fisher, E., Thomas, K. H., Hearn, L., Derry, S., Stannard, C., Knaggs, R., & Moore, R. A. (2017). Interventions for the reduction of prescribed opioid use in chronic non-cancer pain. Cochrane Database of Systematic Reviews, 2017(11), CD010323. https://doi.org/10.1002/14651858.CD010323.pub3
Elman, I., Borsook, D., & Volkow, N. D. (2013). Pain and suicidality: Insights from reward and addiction neuroscience. Progress in Neurobiology, 109, 1–27. https://doi.org/10.1016/j.pneurobio.2013.06.003
Els, C., Jackson, T. D., Hagtvedt, R., Kunyk, D., Sonnenberg, B., Lappi, V. G., & Straube, S. (2023). High-dose opioids for chronic non-cancer pain: An overview of Cochrane Reviews. Cochrane Database of Systematic Reviews, 2023(3), CD012299. https://doi.org/10.1002/14651858.CD012299.pub3
Hamilton, M., Gnjidic, D., Lin, C.-W. C., Jansen, J., Weir, K. R., Ahaheed, C. A., Blyth, F., & Mathieson, S. (2022). Opioid deprescribing: Qualitative perspectives from those with chronic non-cancer pain. Research in Social and Administrative Pharmacy, 18(12), 4083–4091. https://doi.org/10.1016/j.sapharm.2022.07.043
Hickling, L. M., Allani, S., Cella, M., & Scott, W. (2024). A systematic review with meta-analyses of the association between stigma and chronic pain outcomes. Pain, 165(8), 1689–1701. https://doi.org/10.1097/j.pain.0000000000003243
Hooley, J. M., Franklin, J. C., & Nock, M. K. (2014). Chronic pain and suicide: Understanding the association. Current Pain and Headache Reports, 18, 435. https://doi.org/10.1007/s11916-014-0435-2
Hooten, W. M. (2016). Chronic pain and mental health disorders: Shared neural mechanisms, epidemiology, and treatment. Mayo Clinic Proceedings, 91(7), 955–970. https://doi.org/10.1016/j.mayocp.2016.04.029
Kwon, C.-Y., & Lee, B. (2023). Prevalence of suicidal behavior in patients with chronic pain: A systematic review and meta-analysis of observational studies. Frontiers in Psychology, 14, 1217299. https://doi.org/10.3389/fpsyg.2023.1217299
Langford, A. V., Lin, C. C. W., Bero, L., Blyth, F. M., Doctor, J., Holliday, S., Jeon, Y.-H., Moullin, J., Murnion, B., Nielsen, S., Osman, R., Penm, J., Reeve, E., Reid, S., Wale, J., Schneider, C. R., & Gnjidic, D. (2023). Clinical practice guideline for deprescribing opioid analgesics: Summary of recommendations. The Medical Journal of Australia, 219(2), 80–89. https://doi.org/10.5694/mja2.52002
Lee, Y. K., Gold, M. S., Blum, K., Thanos, P. K., Hanna, C., & Fuehrlein, B. S. (2024). Opioid use disorder: Current trends and potential treatments. Frontiers in Public Health, 11, 1274719. https://doi.org/10.3389/fpubh.2023.1274719
McNeilage, A. G., Avery, N. S., Holliday, S., Glare, P. A., & Ashton-James, C. E. (2022). A qualitative trajectory analysis of patients’ experiences tapering opioids for chronic pain. Pain, 163(2), 246–260. https://doi.org/10.1097/j.pain.0000000000002336
Quinlan, J., Willson, H., & Grange, K. (2021). Hopes and fears before opioid tapering: A quantitative and qualitative study of patients with chronic pain and long-term opioids. British Journal of Pain, 15(2), 120–128. https://doi.org/10.1177/2049463720974053
Strang, J., Volkow, N. D., Degenhardt, L., Hickman, M., Johnson, K., Koob, G. F., Marshall, B. D. L., Tyndall, M., & Walsh, S. (2020). Opioid use disorder. Nature Reviews Disease Primers, 6, 3. https://doi.org/10.1038/s41572-019-0137-5
Treede, R.-D., Rief, W., Barke, A., Aziz, Q., Bennett, M. I., Benoliel, R., Cohen, M., Evers, S., Finnerup, N. B., First, M. B., Giamberardino, M. A., Kaasa, S., Kosek, E., Lavand’homme, P., Nicholas, M., Perrot, S., Scholz, J., Schug, S., Smith, B. H., Svensson, P., Vlaeyen, J. W. S., & Wang, S.-J. (2015). A classification of chronic pain for ICD-11. Pain, 156(6), 1003–1007. https://doi.org/10.1097/j.pain.0000000000000160
Wilson, K. G., Kowal, J., Henderson, P. R., McWilliams, L. A., & Péloquin, K. (2013). Chronic pain and the interpersonal theory of suicide. Rehabilitation Psychology, 58(1), 111–115. https://doi.org/10.1037/a0031390
Wołoszyn, B., Rzeźnik, P., Sobczyk, M., Stachera, W., Guzowska, J., Chajnowska, A., Borowy, A., Suchcicka, W., Zach, M., & Stępień, J. (2025). Chronic pain and depression: Correlation and treatment—A review of current literature. Quality in Sport, 43, 61351. https://doi.org/10.12775/QS.2025.43.61351
Yarborough, B. J. H., Stumbo, S. P., Schneider, J. L., Ahmedani, B. K., Daida, Y. G., Hooker, S. A., Lapham, G. T., Negriff, S., & Rossom, R. C. (2024). Patient perspectives on mental health and pain management support needed versus received during opioid deprescribing. The Journal of Pain, 25(7), 104485. https://doi.org/10.1016/j.jpain.2024.01.350
Yarborough, B. J. H., Stumbo, S. P., Schneider, J. L., Ahmedani, B. K., Daida, Y. G., Hooker, S. A., Negriff, S., Rossom, R. C., & Lapham, G. (2024). Impact of opioid dose reductions on patient-reported mental health and suicide-related behavior and relationship to patient choice in tapering decisions. The Journal of Pain, 25(4), 1094–1105. https://doi.org/10.1016/j.jpain.2023.11.002
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Mateusz Wnęk, Michał Adam Łebek, Wiktoria Zofia Komornik, Jakub Jan Piec, Damian Grębosz, Wojciech Kukiełka, Bartłomiej Andrzej Sałapski, Dominika Weronika Brożyna, Jarosław Dudek, Jakub Dawid Gałwiaczek

This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.

